Table 2.
Adjusted associations with loneliness.
| Outcome | Model 1 | Model 2 | Model 3 | ||||||
| Beta | SE | p value | Beta | SE | p value | Beta | SE | p value | |
|
| |||||||||
| Gait speed test (seconds) | 0.192 | 0.022 | <0.0001 | 0.097 | 0.026 | 0.0002 | 0.096 | 0.026 | 0.0003 |
| Grip strength (right hand) | −0.382 | 0.097 | <0.0001 | −0.170 | 0.117 | 0.1471 | −0.168 | 0.118 | 0.1530 |
| 400 m walk time | 0.034 | 0.029 | 0.2451 | 0.038 | 0.035 | 0.2759 | 0.037 | 0.035 | 0.2839 |
| SF-36 general health | 0.140 | 0.011 | <0.0001 | 0.035 | 0.012 | 0.0057 | 0.035 | 0.013 | 0.0058 |
| HbA1c% | 0.030 | 0.020 | 0.1372 | 0.009 | 0.023 | 0.6868 | 0.010 | 0.023 | 0.6632 |
|
| |||||||||
| OR | 95% CI | p value | OR | 95% CI | p value | OR | 95% CI | p value | |
|
| |||||||||
| PAT-D > 1 | 1.470 | 1.313–1.645 | <0.0001 | 1.243 | 1.085–1.424 | 0.0017 | 1.245 | 1.087–0.427 | 0.0016 |
| PHQ-9 > 0 | 1.897 | 1.723–2.088 | <0.0001 | 1.752 | 1.585–1.938 | <0.0001 | 1.754 | 1.586–1.939 | <0.0001 |
| Taking antidepressants | 1.319 | 1.242–1.401 | <0.0001 | 1.126 | 1.048–1.211 | 0.0013 | 1.127 | 1.048–1.211 | 0.0012 |
Note. Model 1: adjusts for age, sex, and race/ethnicity. Model 2: Model 1 plus depressive symptoms (PHQ-9) and antidepressant medication use. Also includes major diabetes med categories for HbA1c outcome (biguanide, insulin, sulfonylurea, and TZD) PHQ-9 outcome does not adjust for depressive symptoms. Taking antidepressants outcome does not adjust for antidepressant medication use. Model 3: Model 2 plus treatment arm.